Genetic and molecular characterization of metabolic pathway-based clusters in esophageal squamous cell carcinoma

Abstract Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive types of squamous cell carcinoma and represents a significant proportion of esophageal cancer. Metabolic reprogramming plays a key role in the occurrence and development of ESCC. Unsupervised clustering analysis was emp...

Full description

Bibliographic Details
Main Authors: Ze Wang, Yuan Zhang, Xiaorong Yang, Tongchao Zhang, Zhen Li, Yang Zhong, Yuan Fang, Wei Chong, Hao Chen, Ming Lu
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-56391-w
_version_ 1797259377850187776
author Ze Wang
Yuan Zhang
Xiaorong Yang
Tongchao Zhang
Zhen Li
Yang Zhong
Yuan Fang
Wei Chong
Hao Chen
Ming Lu
author_facet Ze Wang
Yuan Zhang
Xiaorong Yang
Tongchao Zhang
Zhen Li
Yang Zhong
Yuan Fang
Wei Chong
Hao Chen
Ming Lu
author_sort Ze Wang
collection DOAJ
description Abstract Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive types of squamous cell carcinoma and represents a significant proportion of esophageal cancer. Metabolic reprogramming plays a key role in the occurrence and development of ESCC. Unsupervised clustering analysis was employed to stratify ESCC samples into three clusters: MPC1-lipid type, MPC2-amino acid type, and MPC3-energy type, based on the enrichment scores of metabolic pathways extracted from the Reactome database. The MPC3 cluster exhibited characteristics of energy metabolism, with heightened glycolysis, cofactors, and nucleotide metabolism, showing a trend toward increased aggressiveness and poorer survival rates. On the other hand, MPC1 and MPC2 primarily involved lipid and amino acid metabolism, respectively. In addition, liquid chromatography‒mass spectrometry-based metabolite profiles and potential therapeutic agents were explored and compared among ESCC cell lines with different MPCs. MPC3 amplified energy metabolism markers, especially carnitines. In contrast, MPC1 and MPC2 predominantly had elevated levels of lipids (primarily triacylglycerol) and amino acids, respectively. Furthermore, MPC3 demonstrated a suboptimal clinical response to PD-L1 immunotherapy but showed increased sensitivity to the doramapimod chemotherapy regimen, as evident from drug sensitivity evaluations. These insights pave the way for a more personalized therapeutic approach, potentially enhancing treatment precision for ESCC patients.
first_indexed 2024-04-24T23:08:28Z
format Article
id doaj.art-c1eaf34824524fce99d1ef764dc9b68f
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-24T23:08:28Z
publishDate 2024-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-c1eaf34824524fce99d1ef764dc9b68f2024-03-17T12:22:35ZengNature PortfolioScientific Reports2045-23222024-03-0114111510.1038/s41598-024-56391-wGenetic and molecular characterization of metabolic pathway-based clusters in esophageal squamous cell carcinomaZe Wang0Yuan Zhang1Xiaorong Yang2Tongchao Zhang3Zhen Li4Yang Zhong5Yuan Fang6Wei Chong7Hao Chen8Ming Lu9Clinical Epidemiology Unit, Clinical Research Center of Shandong University, Qilu Hospital of Shandong UniversityClinical Epidemiology Unit, Clinical Research Center of Shandong University, Qilu Hospital of Shandong UniversityClinical Epidemiology Unit, Clinical Research Center of Shandong University, Qilu Hospital of Shandong UniversityClinical Epidemiology Unit, Clinical Research Center of Shandong University, Qilu Hospital of Shandong UniversityClinical Epidemiology Unit, Clinical Research Center of Shandong University, Qilu Hospital of Shandong UniversityClinical Epidemiology Unit, Clinical Research Center of Shandong University, Qilu Hospital of Shandong UniversityClinical Epidemiology Unit, Clinical Research Center of Shandong University, Qilu Hospital of Shandong UniversityDepartment of Gastrointestinal Surgery, Key Laboratory of Engineering of Shandong Province, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical SciencesClinical Epidemiology Unit, Clinical Research Center of Shandong University, Qilu Hospital of Shandong UniversityClinical Epidemiology Unit, Clinical Research Center of Shandong University, Qilu Hospital of Shandong UniversityAbstract Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive types of squamous cell carcinoma and represents a significant proportion of esophageal cancer. Metabolic reprogramming plays a key role in the occurrence and development of ESCC. Unsupervised clustering analysis was employed to stratify ESCC samples into three clusters: MPC1-lipid type, MPC2-amino acid type, and MPC3-energy type, based on the enrichment scores of metabolic pathways extracted from the Reactome database. The MPC3 cluster exhibited characteristics of energy metabolism, with heightened glycolysis, cofactors, and nucleotide metabolism, showing a trend toward increased aggressiveness and poorer survival rates. On the other hand, MPC1 and MPC2 primarily involved lipid and amino acid metabolism, respectively. In addition, liquid chromatography‒mass spectrometry-based metabolite profiles and potential therapeutic agents were explored and compared among ESCC cell lines with different MPCs. MPC3 amplified energy metabolism markers, especially carnitines. In contrast, MPC1 and MPC2 predominantly had elevated levels of lipids (primarily triacylglycerol) and amino acids, respectively. Furthermore, MPC3 demonstrated a suboptimal clinical response to PD-L1 immunotherapy but showed increased sensitivity to the doramapimod chemotherapy regimen, as evident from drug sensitivity evaluations. These insights pave the way for a more personalized therapeutic approach, potentially enhancing treatment precision for ESCC patients.https://doi.org/10.1038/s41598-024-56391-w
spellingShingle Ze Wang
Yuan Zhang
Xiaorong Yang
Tongchao Zhang
Zhen Li
Yang Zhong
Yuan Fang
Wei Chong
Hao Chen
Ming Lu
Genetic and molecular characterization of metabolic pathway-based clusters in esophageal squamous cell carcinoma
Scientific Reports
title Genetic and molecular characterization of metabolic pathway-based clusters in esophageal squamous cell carcinoma
title_full Genetic and molecular characterization of metabolic pathway-based clusters in esophageal squamous cell carcinoma
title_fullStr Genetic and molecular characterization of metabolic pathway-based clusters in esophageal squamous cell carcinoma
title_full_unstemmed Genetic and molecular characterization of metabolic pathway-based clusters in esophageal squamous cell carcinoma
title_short Genetic and molecular characterization of metabolic pathway-based clusters in esophageal squamous cell carcinoma
title_sort genetic and molecular characterization of metabolic pathway based clusters in esophageal squamous cell carcinoma
url https://doi.org/10.1038/s41598-024-56391-w
work_keys_str_mv AT zewang geneticandmolecularcharacterizationofmetabolicpathwaybasedclustersinesophagealsquamouscellcarcinoma
AT yuanzhang geneticandmolecularcharacterizationofmetabolicpathwaybasedclustersinesophagealsquamouscellcarcinoma
AT xiaorongyang geneticandmolecularcharacterizationofmetabolicpathwaybasedclustersinesophagealsquamouscellcarcinoma
AT tongchaozhang geneticandmolecularcharacterizationofmetabolicpathwaybasedclustersinesophagealsquamouscellcarcinoma
AT zhenli geneticandmolecularcharacterizationofmetabolicpathwaybasedclustersinesophagealsquamouscellcarcinoma
AT yangzhong geneticandmolecularcharacterizationofmetabolicpathwaybasedclustersinesophagealsquamouscellcarcinoma
AT yuanfang geneticandmolecularcharacterizationofmetabolicpathwaybasedclustersinesophagealsquamouscellcarcinoma
AT weichong geneticandmolecularcharacterizationofmetabolicpathwaybasedclustersinesophagealsquamouscellcarcinoma
AT haochen geneticandmolecularcharacterizationofmetabolicpathwaybasedclustersinesophagealsquamouscellcarcinoma
AT minglu geneticandmolecularcharacterizationofmetabolicpathwaybasedclustersinesophagealsquamouscellcarcinoma